Bio-Rad Laboratories, Inc.Class A: tracked funds
BIOfinancial statementsinsider trading
No tracked fund reported a position in Bio-Rad Laboratories, Inc.Class A (BIO) in its latest 13F filing, through August 14, 2026. The managers we follow, and what they hold, are on tracked funds.
Questions
Which hedge funds own BIO?
None of the 18 tracked managers reported a position in Bio-Rad Laboratories, Inc.Class A in its latest 13F filing.
What is a 13F and what does it miss?
Managers with $100 million or more in US equities report their long positions on Form 13F each quarter, up to 45 days after it ends. The filing omits short positions, bonds, cash and most foreign listings, and a position may have changed since the quarter ended. Options are excluded here.
From the managers’ Form 13F-HR filings with the SEC, amendments applied, share counts adjusted for splits; GOOG and GOOGL are one position. A record of filings, not a recommendation.